AMOXICILLINE ACIDE CLAVULANIQUE ARROW 100 mg/12.5 mg per ml for infants, powder for oral suspension in a vial (ratio amoxicillin/clavulanic acid : 8/1) bottle, 5.25 g
Active ingredients: Clavulanic acid, Amoxicillin, Amoxicillin trihydrate, Clavulanate potassium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspensionbottle, 5.25 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMOXICILLINE ACIDE CLAVULANIQUE ARROW 100 mg/12,5 mg par mL NOURRISSONS, poudre pour suspension buvable en flacon (rapport amoxicilline/acide clavulanique : 8/1)
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 5,25 g de poudre avec seringue(s) pour administration orale polyéthylène polystyrène
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 24 Apr 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69033903CIP73594827CIP133400935948274Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AMOXICILLINEpoudre | 100 mg · 1 ml de suspension reconstituée | FT |
| AMOXICILLINE TRIHYDRATÉEpoudre | — | SA |
| CLAVULANATE DE POTASSIUMpoudre | — | SA |
| ACIDE CLAVULANIQUEpoudre | 12,50 mg · 1 ml de suspension reconstituée | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.